Latest Period
Q2 2026
Security Snapshot
Biohaven Ltd. - Common Shares, no par value per share (BHVN) Institutional Ownership
CUSIP: G1110E107
13F Institutional Holders and Ownership History from Q2 2022 to Q2 2026
Institutions Reporting
293
Shares (Excl. Options)
141,053,227
Price
$14.88
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Shares, no par value per share
- Symbol
- BHVN on NYSE
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 141,053,227
- Total 13F value
- $2,098,423,802
- Portfolio coverage rank
- 0%
- Share change
- +8,375,958
- Value change
- +$157,833,622
- Number of holders
- 293
- Shares outstanding
- 150,201,569
- SEC-reported price per share
- $14.65
- Insider filing price
- $14.65
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- BHVN - Biohaven Ltd. - Common Shares, no par value per share is tracked under CUSIP G1110E107.
- 293 institutions reported positions in Q2 2026.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 277 to 293 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $1,202,443,039 to $2,098,423,802.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 293 institutions filings for Q2 2026.
Security key
G1110E107
Latest holder period
Q2 2026
13F holders
293
13D/G owners
4
CIK / CUSIP context first
Open Q2 2026 holders
BHVN full holder history
Biohaven Ltd. SEC filings
Biohaven Ltd. company facts
Biohaven Ltd. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP G1110E107:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
BHVN
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7.8% | $116,139,519 | 10,286,937 | SUVRETTA CAPITAL MANAGEMENT, LLC | 31 Dec 2025 | |||
| Janus Henderson Group Ltd. | 5.7% | -50% | $127,742,554 | -$133,177,733 | 8,584,676 | -51% | JANUS HENDERSON GROUP Ltd. | 30 Jun 2026 |
| Woodline Partners LP | 5.1% | $120,726,013 | 7,660,280 | Woodline Partners LP | 30 Jun 2026 | |||
| VANGUARD GROUP INC | 2.7% | $43,156,602 | 2,875,190 | The Vanguard Group | 30 Sep 2025 |
As of 30 Jun 2026, 293 institutional investors reported holding 141,053,227 shares of Biohaven Ltd. - Common Shares, no par value per share (BHVN). This represents 94% of the company’s total 150,201,569 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
70%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 8.8% | 13,210,585 | +18% | 0% | $196,573,505 |
| MONTANOVA CAPITAL, LLC | 6.8% | 10,286,937 | 0% | 3.2% | $153,069,623 |
| STIFEL FINANCIAL CORP | 6.6% | 9,941,165 | +0% | 0.12% | $147,924,530 |
| Jupiter Topco LLC | 5.7% | 8,584,675 | 0% | 0.05% | $127,851,575 |
| Woodline Partners LP | 5.1% | 7,660,280 | +2450% | 0.35% | $113,984,966 |
| STATE STREET CORP | 4.6% | 6,947,034 | +5% | 0% | $103,371,866 |
| INFINITUM ASSET MANAGEMENT, LLC | 4.2% | 6,250,000 | 0% | 9.6% | $93,000,000 |
| D. E. Shaw & Co., Inc. | 2.8% | 4,190,195 | +47% | 0.04% | $62,350,102 |
| AQR CAPITAL MANAGEMENT LLC | 2.8% | 4,150,616 | +110% | 0.02% | $61,761,159 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.2% | 3,323,190 | +20% | 0% | $49,460,273 |
| FMR LLC | 2% | 2,964,630 | +26% | 0% | $44,113,698 |
| Royalty Pharma Sub-Manager, LLC | 2% | 2,936,507 | 0% | 18% | $43,695,224 |
| Cormorant Asset Management, LP | 1.7% | 2,610,000 | +48% | 2% | $38,836,800 |
| GOLDMAN SACHS GROUP INC | 1.7% | 2,583,046 | +2.8% | 0% | $38,435,724 |
| UBS Group AG | 1.7% | 2,518,827 | +77% | 0.01% | $37,480,146 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.7% | 2,488,941 | +9.2% | 0% | $37,035,442 |
| Balyasny Asset Management L.P. | 1.3% | 1,879,734 | -23% | 0.05% | $27,970,442 |
| TCG Crossover Management, LLC | 1.2% | 1,779,952 | -62% | 0.64% | $26,485,686 |
| Nuveen, LLC | 1.2% | 1,744,334 | +134% | 0.01% | $25,955,690 |
| Rubric Capital Management LP | 1.1% | 1,721,493 | 0.23% | $25,615,816 | |
| CITADEL ADVISORS LLC | 1.1% | 1,619,676 | -6% | 0.01% | $24,100,779 |
| VANGUARD CAPITAL MANAGEMENT LLC | 0.99% | 1,488,809 | +17% | 0% | $22,153,478 |
| BANK OF AMERICA CORP /DE/ | 0.98% | 1,477,838 | +95% | 0% | $21,990,229 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.97% | 1,456,851 | -34% | 0% | $21,679,000 |
| ARS Investment Partners, LLC | 0.91% | 1,374,185 | -0.34% | 0.89% | $20,447,873 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
17
Latest
Q2 2026
Rows shown
1-17 of 17
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 141,053,227 | $2,098,423,802 | +$157,833,622 | $14.88 | 293 |
| 2026 Q1 | 142,084,932 | $1,202,443,039 | +$181,093,762 | $8.46 | 277 |
| 2025 Q4 | 121,437,146 | $1,371,219,974 | +$339,162,643 | $11.29 | 271 |
| 2025 Q3 | 84,320,326 | $1,263,904,622 | -$38,241,337 | $15.01 | 261 |
| 2025 Q2 | 86,987,421 | $1,227,652,713 | -$143,894,992 | $14.11 | 247 |
| 2025 Q1 | 88,106,650 | $2,142,495,070 | -$115,214,537 | $24.04 | 260 |
| 2024 Q4 | 89,346,784 | $3,336,885,126 | +$168,942,579 | $37.35 | 253 |
| 2024 Q3 | 86,165,783 | $4,306,353,110 | +$148,383,281 | $49.97 | 250 |
| 2024 Q2 | 82,422,187 | $2,860,885,986 | +$210,746,356 | $34.71 | 222 |
| 2024 Q1 | 74,154,350 | $4,055,673,624 | +$161,363,053 | $54.69 | 239 |
| 2023 Q4 | 71,802,540 | $3,073,238,412 | +$434,075,584 | $42.80 | 214 |
| 2023 Q3 | 61,463,892 | $1,598,669,852 | +$39,755,212 | $26.01 | 183 |
| 2023 Q2 | 60,120,418 | $1,438,087,383 | -$122,838,089 | $23.92 | 183 |
| 2023 Q1 | 66,543,203 | $909,962,550 | +$54,642,668 | $13.66 | 171 |
| 2022 Q4 | 62,449,262 | $868,331,200 | +$266,710,670 | $13.88 | 168 |
| 2022 Q3 | 3,316,172 | $499,083,000 | +$491,524,000 | $151.17 | 29 |
| 2022 Q2 | $23.92 | 0 |